Biogen is working with Columbia University Medical Center to build a database of genes and clinical traits from 1,500 people with amyotrophic lateral sclerosis (ALS). The project, which is partly funded by cash raised in the Ice Bucket Challenge, is intended to help Biogen understand how genes contribute to different forms of ALS.
Intel has unveiled its pitch to become the organization that pulls cancer data out of silos. The semiconductor giant has spent the past two years working on the problem with Oregon Health & Science University, bringing it to the point at which it is ready to open up the platform to other organizations.
YouTube users upload 300 hours of video every minute. If the site keeps growing at its current rate, researchers think users could be uploading 1,700 hours of video a minute by 2025, a total that would amount to 2 exabytes of data per year. Yet if a new analysis is right, the computing crunch facing genomics could dwarf these challenges.
Core Informatics has closed a $17.5 million Series B round to bankroll its campaign to capture an ever-growing slice of the LIMS and ELN markets. The cash will fund an across-the-board hiring spree and swell Core Informatics' current 65-strong headcount by 50% over the next 5 months.
Eisai has become the latest in a long line of companies to look to IT outsourcing for cost savings. The drugmaker has handed responsibility for the maintenance, operation and monitoring of much of its IT infrastructure in Japan and the U.S. to Accenture in a pair of long-term deals.
With the clinical trial community gathering for DIA 2015, eClinical tech vendors have been rolling out releases about their new tools, hires and deals. Here we round up a batch of notable news, including a new hire at Clinical Ink, deals for DocuSign and a visit to the FDA by Nextrials.
The United Kingdom's botched and aborted attempt to share certain patient healthcare data with drug developers and other groups has triggered another controversy. Officials responsible for sharing the data have admitted they are unable to handle the 700,000 requests by patients to opt out of the program.
Israel has become the latest country to disclose plans to create a population-scale database of linked genetic and clinical records. The current plan is reminiscent of the United Kingdom's 100,000 Genomes Project, with Israel considering working with tech firms to create a database of patients with rare genetic diseases.
The Allen Institute for Brain Science has released an online database of neuron cell types, building blocks it thinks will lead to the creation of computer models of healthy brains. Publication of the free database marks an important, early milestone for the research program triggered by a $300 million donation from Microsoft co-founder Paul Allen in 2012.
Bina Technologies has unveiled its first publicly known deal with a Big Pharma since it was bought by Roche. The agreement sees AstraZeneca tighten its ties to the genomic data analysis platform provider by becoming the first member of the Bina Alliance Program.